Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Valvular Heart Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 87 articles:
HTML format



Single Articles


    January 2024
  1. SCHENKER C, Wertli MM, Raber L, Haynes AG, et al
    Regional variation and temporal trends in transcatheter and surgical aortic valve replacement in Switzerland: A population-based small area analysis.
    PLoS One. 2024;19:e0296055.
    PubMed     Abstract available


  2. PERMSUWAN U, Singhatanadgige S, Boonpipattanapong K, Slisatkorn W, et al
    Cost-utility analysis of sutureless and rapid deployment versus conventional aortic valve replacement in patients with moderate to severe aortic stenosis in Thailand.
    PLoS One. 2024;19:e0296875.
    PubMed     Abstract available


  3. NAKAYAMA T, Yamamoto J, Ozeki T, Tokoroyama S, et al
    Impact of an angulated aorto-septal relationship on cardio-cerebrovascular outcomes in patients undergoing hemodialysis.
    PLoS One. 2024;19:e0298637.
    PubMed     Abstract available


    January 2023
  4. CHOE J, Koo HJ, Choi SJ, Lee SA, et al
    Differences in aortic valve area measured on cardiac CT and echocardiography in patients with aortic stenosis.
    PLoS One. 2023;18:e0280530.
    PubMed     Abstract available


  5. CONNOCK M, Auguste P, Obadia JF, Andronis L, et al
    Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair.
    PLoS One. 2023;18:e0280554.
    PubMed     Abstract available


  6. RHO J, Shin SM, Jhang K, Lee G, et al
    Deep learning-based diagnosis of feline hypertrophic cardiomyopathy.
    PLoS One. 2023;18:e0280438.
    PubMed     Abstract available


  7. KOYUNCU A, Yildiz C, Ocal L, Kalkan S, et al
    Does papillary muscle free strain has predictive value in risk stratification of patients with hypertrophic cardiomyopathy?
    PLoS One. 2023;18:e0282054.
    PubMed     Abstract available


  8. JOSHUA J, Caswell J, O'Sullivan ML, Wood G, et al
    Feline myocardial transcriptome in health and in hypertrophic cardiomyopathy-A translational animal model for human disease.
    PLoS One. 2023;18:e0283244.
    PubMed     Abstract available


  9. BEGUN X, Butt JH, Kristensen SL, Weeke PE, et al
    Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study.
    PLoS One. 2023;18:e0282636.
    PubMed     Abstract available


  10. GONG K, Yang K, Xie T, Luo Y, et al
    Identification of circRNA-miRNA-mRNA regulatory network and its role in cardiac hypertrophy.
    PLoS One. 2023;18:e0279638.
    PubMed     Abstract available


  11. AHMED Y, van Bakel PAJ, Hou H, Sukul D, et al
    Racial and ethnic disparities in diagnosis, management and outcomes of aortic stenosis in the Medicare population.
    PLoS One. 2023;18:e0281811.
    PubMed     Abstract available


  12. AKIYAMA N, Suzuki R, Saito T, Yuchi Y, et al
    Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan.
    PLoS One. 2023;18:e0283433.
    PubMed     Abstract available


  13. TADESSE KD, Gebru M, Tekleab AM
    Treatment outcome of patients with prosthetic stuck valves at the Cardiac Center of Ethiopia.
    PLoS One. 2023;18:e0284652.
    PubMed     Abstract available


  14. CHUNG CH, Wang YJ, Jiao X, Lee CY, et al
    Transcatheter aortic valve implantation vs. surgical aortic valve replacement for aortic stenosis in Taiwan: A population-based cohort study.
    PLoS One. 2023;18:e0285191.
    PubMed     Abstract available


  15. HWANG JW, Lee SC, Kim D, Kim J, et al
    Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
    PLoS One. 2023;18:e0285887.
    PubMed     Abstract available


  16. CHETBOUL V, Bernard P, Passavin P, Tissier R, et al
    Congenital ventricular outflow tract obstructions in Boxer dogs: Results of a 17-year cardiovascular breed screening program in France (3126 dogs).
    PLoS One. 2023;18:e0285458.
    PubMed     Abstract available


  17. KWAN JM, Arbune A, Henry ML, Hu R, et al
    Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients.
    PLoS One. 2023;18:e0286364.
    PubMed     Abstract available


  18. MENG L, Yang H, Xin S, Chang C, et al
    Association of red blood cell distribution width-to-albumin ratio with mortality in patients undergoing transcatheter aortic valve replacement.
    PLoS One. 2023;18:e0286561.
    PubMed     Abstract available


  19. LIEBENBERG J, Doubell A, Laubscher R, Herbst P, et al
    In-silico modelling of the impact of hypertension on the mean transvalvular gradients in aortic stenosis.
    PLoS One. 2023;18:e0286644.
    PubMed     Abstract available


  20. GRACIA BAENA JM, Marsal Mora JR, Llorca Cardenosa S, Calaf Vall I, et al
    Impact of severe aortic stenosis on quality of life.
    PLoS One. 2023;18:e0287508.
    PubMed     Abstract available


  21. PARK J, Yoon YE, Chun EJ, Choi HM, et al
    Endocardial versus whole-myocardial tracking global longitudinal strain analysis in patients with hypertrophic cardiomyopathy: A preliminary comparative study.
    PLoS One. 2023;18:e0288421.
    PubMed     Abstract available


  22. WESSELOWSKI S, Lidbury J, Saunders AB, Gordon SG, et al
    Analytical validation, sample stability, and clinical evaluation of a new high-sensitivity cardiac troponin I immunoassay for use in dogs, with comparison to a previous ultrasensitive assay.
    PLoS One. 2023;18:e0288801.
    PubMed     Abstract available


  23. CHO YJ, Hyeon C, Nam K, Lee S, et al
    Effects of low versus high inspired oxygen fraction on myocardial injury after transcatheter aortic valve implantation: A randomized clinical trial.
    PLoS One. 2023;18:e0281232.
    PubMed     Abstract available


  24. HUANG M, Guan R, Qiu J, Gnamey AJE, et al
    Identification of immune-related signatures and pathogenesis differences between thoracic aortic aneurysm patients with bicuspid versus tricuspid valves via weighted gene co-expression network analysis.
    PLoS One. 2023;18:e0292673.
    PubMed     Abstract available


  25. IOAKEIMIDIS NS, Pitsis A, Zegkos T, Ntelios D, et al
    Periostin is overexpressed, correlated with fibrosis and differs among grades of cardiomyocyte hypertrophy in myectomy tissue of patients with hypertrophic cardiomyopathy.
    PLoS One. 2023;18:e0293427.
    PubMed     Abstract available


  26. VODNJOV N, Toplisek J, Maver A, Cuturilo G, et al
    A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study.
    PLoS One. 2023;18:e0294969.
    PubMed     Abstract available


    January 2022
  27. LEE JM, Park HB, Song JE, Kim IC, et al
    The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0259638.
    PubMed     Abstract available


  28. TONNESSEN TC, Melleby AO, Hauge-Iversen IM, Espe EKS, et al
    Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice.
    PLoS One. 2022;17:e0262821.
    PubMed     Abstract available


  29. HULTKVIST H, Nylander E, Tamas E, Svedjeholm R, et al
    Evaluation of left ventricular diastolic function in patients operated for aortic stenosis.
    PLoS One. 2022;17:e0263824.
    PubMed     Abstract available


  30. LEE HJ, Kim HK, Lee SC, Ommen SR, et al
    Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0264580.
    PubMed     Abstract available


  31. ZHANG C, Liu J, Qin S
    Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263378.
    PubMed     Abstract available


  32. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
    Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
    PLoS One. 2022;17:e0266939.
    PubMed     Abstract available


  33. VICENZI M, Caravita S, Rota I, Casella R, et al
    The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
    PLoS One. 2022;17:e0265059.
    PubMed     Abstract available


  34. GROUND M, Waqanivavalagi S, Park YE, Callon K, et al
    Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells.
    PLoS One. 2022;17:e0270227.
    PubMed     Abstract available


  35. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    PubMed     Abstract available


  36. SALEH QW, Diederichsen ACP, Lindholt JS
    Individualized prediction of risk of ascending aortic syndromes.
    PLoS One. 2022;17:e0270585.
    PubMed     Abstract available


  37. BAGARDI M, Ghilardi S, Zamarian V, Ceciliani F, et al
    Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
    PLoS One. 2022;17:e0266208.
    PubMed     Abstract available


  38. STROM JB, Playford D, Stewart S, Li S, et al
    Increasing risk of mortality across the spectrum of aortic stenosis is independent of comorbidity & treatment: An international, parallel cohort study of 248,464 patients.
    PLoS One. 2022;17:e0268580.
    PubMed     Abstract available


  39. BOUWMEESTER S, van Loon T, Ploeg M, Mast TP, et al
    Left atrial remodeling in mitral regurgitation: A combined experimental-computational study.
    PLoS One. 2022;17:e0271588.
    PubMed     Abstract available


  40. COL NF, Otero D, Lindman BR, Horne A, et al
    What matters most to patients with severe aortic stenosis when choosing treatment? Framing the conversation for shared decision making.
    PLoS One. 2022;17:e0270209.
    PubMed     Abstract available


  41. SAIJO Y, Wang TKM, Chan N, Sperry BW, et al
    Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle.
    PLoS One. 2022;17:e0273419.
    PubMed     Abstract available


  42. BORJESSON E, Svennblad B, Wisten A, Borjesson M, et al
    Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden.
    PLoS One. 2022;17:e0273567.
    PubMed     Abstract available


  43. TRACHOO O, Yingchoncharoen T, Ngernsritrakul T, Iemwimangsa N, et al
    Genomic findings of hypertrophic and dilated cardiomyopathy characterized in a Thai clinical genetics service.
    PLoS One. 2022;17:e0267770.
    PubMed     Abstract available


  44. MOTAZEDIAN F, Ostovar R, Hartrumpf M, Schroter F, et al
    Every day mitral valve reconstruction: What has changed over the last 15 years?
    PLoS One. 2022;17:e0269537.
    PubMed     Abstract available


  45. KIRSCHFINK A, Alachkar MN, Alnaimi A, Vogt F, et al
    Outcome of transcatheter edge-to-edge mitral valve repair in patients with diabetes mellitus: Results from a real-world cohort.
    PLoS One. 2022;17:e0276019.
    PubMed     Abstract available


  46. PARK DY, An S, Hanna JM, Wang SY, et al
    Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease.
    PLoS One. 2022;17:e0276394.
    PubMed     Abstract available


  47. TAKEUCHI M, Suzuki H, Matsumoto Y, Kikuchi Y, et al
    Prediction of the development of delirium after transcatheter aortic valve implantation using preoperative brain perfusion SPECT.
    PLoS One. 2022;17:e0276447.
    PubMed     Abstract available


  48. HUNG HJ, Chung CS, Tai CM, Chang CW, et al
    Clinical characteristics and risk factors for rebleeding in uremic patients with obscure gastrointestinal bleeding undergoing deep enteroscopy: A multi-center retrospective study in Taiwan.
    PLoS One. 2022;17:e0277434.
    PubMed     Abstract available


  49. YOSHIMURA M, Shiramoto H, Koga M, Morimoto Y, et al
    Preoperative echocardiography predictive analytics for postinduction hypotension prediction.
    PLoS One. 2022;17:e0278140.
    PubMed     Abstract available


  50. GHILARDI S, Lecchi C, Bagardi M, Romito G, et al
    Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
    PLoS One. 2022;17:e0274724.
    PubMed     Abstract available


  51. MORI M, Zogg CK, Amabile A, Fereydooni S, et al
    Impact of secondary mitral regurgitation on survival in atrial and ventricular dysfunction.
    PLoS One. 2022;17:e0277385.
    PubMed     Abstract available


    January 2021
  52. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed     Abstract available


  53. TAYAL B, Malahfji M, Buergler JM, Shah DJ, et al
    Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study.
    PLoS One. 2021;16:e0245934.
    PubMed     Abstract available


  54. WIENER PC, Darwish A, Friend E, Kadem L, et al
    Energy loss associated with in-vitro modeling of mitral annular calcification.
    PLoS One. 2021;16:e0246701.
    PubMed     Abstract available


  55. RADBILL AE, Lei LY, Paranjape SY, Blackwell DJ, et al
    Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0246768.
    PubMed     Abstract available


  56. TANIGUCHI Y, Sakakura K, Nomura Y, Hatori M, et al
    Comparison of long-term outcomes after trans-catheter aortic valve implantation between patients primarily diagnosed by cardiac murmur and those diagnosed by other reasons.
    PLoS One. 2021;16:e0247588.
    PubMed     Abstract available


  57. GODLEWSKI K, Dryzek P, Sadurska E, Werner B, et al
    Left ventricular systolic function impairment in children after balloon valvuloplasty for congenital aortic stenosis assessed by 2D speckle tracking echocardiography.
    PLoS One. 2021;16:e0248862.
    PubMed     Abstract available


  58. KVASLERUD AB, Santic K, Hussain AI, Auensen A, et al
    Outcomes in asymptomatic, severe aortic stenosis.
    PLoS One. 2021;16:e0249610.
    PubMed     Abstract available


  59. PETRYKA-MAZURKIEWICZ J, Ziolkowska L, Mazurkiewicz L, Kowalczyk-Domagala M, et al
    Right-ventricular mechanics assessed by cardiovascular magnetic resonance feature tracking in children with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0248725.
    PubMed     Abstract available


  60. HAMMER Y, Talmor-Barkan Y, Abelow A, Orvin K, et al
    Myocardial extracellular volume quantification by computed tomography predicts outcomes in patients with severe aortic stenosis.
    PLoS One. 2021;16:e0248306.
    PubMed     Abstract available


  61. ROY D, Mazumder O, Sinha A, Khandelwal S, et al
    Multimodal cardiovascular model for hemodynamic analysis: Simulation study on mitral valve disorders.
    PLoS One. 2021;16:e0247921.
    PubMed     Abstract available


  62. CHOUAIRI F, Mullan CW, Sen S, Mori M, et al
    Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.
    PLoS One. 2021;16:e0247789.
    PubMed     Abstract available


  63. KUSNER J, Luraghi G, Khodaee F, Rodriguez Matas JF, et al
    Understanding TAVR device expansion as it relates to morphology of the bicuspid aortic valve: A simulation study.
    PLoS One. 2021;16:e0251579.
    PubMed     Abstract available


  64. WILLITS I, Keltie K, de Belder M, Henderson R, et al
    Safety, effectiveness and costs of percutaneous mitral valve repair: A real-world prospective study.
    PLoS One. 2021;16:e0251463.
    PubMed     Abstract available


  65. LEMES DA SILVA MV, Nunes Filho ACB, Rosa VEE, Caixeta A, et al
    Improvement of renal function after transcatheter aortic valve replacement in patients with chronic kidney disease.
    PLoS One. 2021;16:e0251066.
    PubMed     Abstract available


  66. AYME-DIETRICH E, Da Silva S, Bouabout GA, Arnoux A, et al
    Characterization of the spontaneous degenerative mitral valve disease in FVB mice.
    PLoS One. 2021;16:e0257022.
    PubMed     Abstract available


  67. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    PubMed     Abstract available


  68. LIAW J, Walker B, Hall L, Gorton S, et al
    Rheumatic heart disease in pregnancy and neonatal outcomes: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253581.
    PubMed     Abstract available


  69. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    PubMed     Abstract available


  70. RIENGVIRODKIJ N, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS.
    PLoS One. 2021;16:e0255611.
    PubMed     Abstract available


  71. ABU KHADIJA H, Gandelman G, Ayyad O, Jaber M, et al
    Differential systemic inflammatory responses after TAVI: The role of self versus balloon expandable devices.
    PLoS One. 2021;16:e0258963.
    PubMed     Abstract available


  72. YAMAWAKI M, Honda Y, Makino K, Nakano T, et al
    Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access.
    PLoS One. 2021;16:e0260385.
    PubMed     Abstract available


  73. DA SILVA TL JR, Pazin-Filho A, Romano MMD, Ferriani VPL, et al
    Mitral valve thickening in acute rheumatic fever as a predictor of late valvar dysfunction.
    PLoS One. 2021;16:e0259737.
    PubMed     Abstract available


    January 2020
  74. OZTURK C, Becher MU, Kalkan A, Kavsur R, et al
    The modified MIDA-Score predicts mid-term outcomes after interventional therapy of functional mitral regurgitation.
    PLoS One. 2020;15:e0236265.
    PubMed     Abstract available


  75. CHANG MC, Wu MT, Weng KP, Chien KJ, et al
    Biventricular myocardial adaptation in patients with repaired tetralogy of Fallot: Mechanistic insights from magnetic resonance imaging tissue phase mapping.
    PLoS One. 2020;15:e0237193.
    PubMed     Abstract available


  76. TRINDADE F, Saraiva F, Keane S, Leite-Moreira A, et al
    Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy.
    PLoS One. 2020;15:e0237000.
    PubMed     Abstract available


  77. FEUILLATRE H, Auffret V, Castro M, Lalys F, et al
    Similarity measures and attribute selection for case-based reasoning in transcatheter aortic valve implantation.
    PLoS One. 2020;15:e0238463.
    PubMed     Abstract available


  78. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    PubMed     Abstract available


  79. JAAKKOLA J, Jaakkola S, Airaksinen KEJ, Husso A, et al
    Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    PLoS One. 2020;15:e0238953.
    PubMed     Abstract available


  80. AL-SHAMMARI H, Latif N, Sarathchandra P, McCormack A, et al
    Expression and function of mechanosensitive ion channels in human valve interstitial cells.
    PLoS One. 2020;15:e0240532.
    PubMed     Abstract available


  81. OKAMOTO R, Goto I, Nishimura Y, Kobayashi I, et al
    Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish.
    PLoS One. 2020;15:e0240129.
    PubMed     Abstract available


  82. PEVERILL RE, Chou B, Donelan L, Thai WE, et al
    Left ventricular long-axis function in hypertrophic cardiomyopathy - Relationships between e`, early diastolic excursion and duration, and systolic excursion.
    PLoS One. 2020;15:e0240296.
    PubMed     Abstract available


  83. JOLL JE 2ND, Clark CR, Peters CS, Raddatz MA, et al
    Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
    PLoS One. 2020;15:e0238407.
    PubMed     Abstract available


  84. AL HAGEH C, Rahy R, Khazen G, Brial F, et al
    Plasma and urine metabolomic analyses in aortic valve stenosis reveal shared and biofluid-specific changes in metabolite levels.
    PLoS One. 2020;15:e0242019.
    PubMed     Abstract available


  85. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    PubMed     Abstract available


  86. MINO T, Kimura S, Kitaura A, Iwamoto T, et al
    Can left ventricular hypertrophy on electrocardiography detect severe aortic valve stenosis?
    PLoS One. 2020;15:e0241591.
    PubMed     Abstract available


  87. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.